公司资料
Galapagos NV 股价、新闻与催化剂
- 股票代码:
- GLPG
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Belgium
股票表现
27.73 USD (-3.75%)
收盘价
最后更新: 2026年5月7日
1.83B USD
市值
股价为何变动
Current closing-price context is not available for GLPG.
公司概览
业务概览
Galapagos is a biotechnology company with a long history in immunology and inflammatory disease, and it has also redefined itself around partnership and pipeline strategy. Its story is shaped by platform science, corporate evolution, and a global footprint.
所在地与行业分类
Galapagos is headquartered in Belgium and listed on NASDAQ. It sits in global specialty biotechnology.
商业模式特征
The company depends on pipeline progress, partnership strategy, and the ability to convert its scientific base into durable value. Investors watch clinical updates, business development, and portfolio direction.
生物医药行业定位
Galapagos occupies a global immunology-biotech niche. The stock is driven by whether the company can keep its innovation engine relevant after strategic shifts.
未来催化剂
- Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform. The market will care more about strategic direction than about broad pipeline optionality.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。